Jnj competitors.

Review the table below to see how Johnson & Johnson stock stands up against its competitors. Click into any of the below tickers to see their stock grades for value, momentum, quality and EPS revisions. Johnson & Johnson (JNJ) Competitors. Companies similar to Johnson & Johnson in the Pharmaceuticals industry.

Jnj competitors. Things To Know About Jnj competitors.

Jun 13, 2023 · Competition is fierce, certainly, with private label adoption one obvious concern. (In pain relief, for instance, the total global market share of private label competitors is more than 1.5x that ... Johnson and Johnson Divisions Annual Report. PROCRIT. 1.67 %. of total Revenue. RISPERDAL. 1.6 %. of total Revenue.Nov 27, 2023 · We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world. In 2022, Johnson & Johnson's sales in the United States came to over 48 billion U.S. dollars. Thus, the largest part of the company’s revenue was generated in the United States. Europe is the ...

Johnson & Johnson Competitors. Country Company Market Cap ROCE US Johnson & Johnson. NYSE:JNJ 353B USD: 21% JP N Nichi-Iko Pharmaceutical Co Ltd. TSE:4541 ...Oct 21, 2023 ... - Lemme disclose that J&J, Johnson & Johnson, has been a long time ... competitors and I don't even know if you're competitors at that ...

Nov 30, 2023 · The average twelve-month price prediction for Johnson & Johnson is $169.19 with a high price target of $215.00 and a low price target of $52.00. Learn more on JNJ's analyst rating history. Do Wall Street analysts like Johnson & Johnson more than its competitors?

Nov 30, 2023 · The average twelve-month price prediction for Johnson & Johnson is $169.19 with a high price target of $215.00 and a low price target of $52.00. Learn more on JNJ's analyst rating history. Do Wall Street analysts like Johnson & Johnson more than its competitors? www.jnj.com: Cheif Executive Officer: Alex Gorsky: Annual Sales Volume (2013) 71.3 Billion: Total Number of Employees: 128,100: Primary SIC Code: 2834 (Pharmaceutical Preparations) Primary NAICS Code: ... Competitors will follow Johnson and Johnson into the natural remedy options .In today’s fast-paced world, home security has become a top priority for homeowners. With advancements in technology, there are now a plethora of options available when it comes to choosing the right home security system. One popular choice...... JNJ and is also a component of the Dow Jones Industrial Average (DJIA). Competition and Market Share. As a healthcare conglomerate, Johnson & Johnson ...

Dec 3, 2023 · Johnson & Johnson main competitors are AbbVie, Bristol-Myers Squibb, and Eli Lilly and Company. Competitor Summary. See how Johnson & Johnson compares to its main competitors: Merck has the most employees (74,000). Employees at AbbVie earn more than most of the competitors, with an average yearly salary of $107,969.

New Consumer Health Company would be a Global Leader with Iconic Brands and Products that Touch Over One Billion Lives Every Day Johnson & Johnson would Remain a Global Leader in Healthcare, Focused on Major Unmet Medical Needs and Materially Advancing Standard of Care through Biopharmaceutical and Medical Device Innovation and Technology Separation Designed to Enhance Operational Performance ...

May 26, 2011 · A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended January 2, 2011. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Slide 1 Strategic Analysis Case Study 2009 Jarryd Phillips, Jermaine West, Spencer Jacoby, Othniel Hyliger, Steven Pelletier 1 Slide 2 Overview Company Overview History Current…View the latest JNJ earnings date, analysts forecasts, earnings history, and conference call transcripts ... Enter your email address below to receive the latest news and analysts' ratings for Johnson & …Competition schedule is subject to change. All Adult competitors must be at Competitor Briefing 12.30pm (with the exception of Novice zouk jnj competitors who must arrive by 10.30am – this category is TBC based on sign ups.Apr 10, 2020 · In a trade war, LLY is substantially more endangered than JNJ its greatest competitors. The annual reports of both JNJ and LLY is explored for the period 2007 to 2016. This was analysed on the ...

JNJ competitors consist of Abbott Laboatories which make baby bottles and sooth aching joints, Eli Lilly which came out with the famous Prozac (which is an antidepressant). Another competitor is Novartis AG which is located in Switzerland but they have been attacking illnesses. JNJ is considerded a large cap since it is 159. 96 billion.Johnson & Johnson plans to spin off its consumer health division that sells Listerine and Baby Powder to focus on pharmaceuticals and medical devices in the biggest shake-up in the U.S. company's ...In the Q3, Johnson And Johnson's corporate clients experienced a decline by -14.12 % in their costs of revenue, compared to a year ago, sequentially costs of revenue were trimmed by -7.17 %. During the corresponding time, Johnson And Johnson revenue deteriorated by -10.26 % year on year, sequentially revenue fell by -16.37 %.When it comes to office suites, there are plenty of options available in the market. One popular choice is WPS Office Free, a feature-packed suite that offers a range of tools for creating and editing documents, spreadsheets, and presentati...Johnson And Johnson' Executive Officers and mambers of the Board - CSIMarketJNJ-2113 is the only targeted oral peptide in late-stage development that is designed to selectively block the IL-23 receptor, and we believe the ICONIC studies have the potential to establish JNJ-2113 as the preferred oral treatment option for psoriasis patients," said Dinesh V. Patel, Ph.D., President and CEO of Protagonist.Commenting Third Quarter 2023 Net Cash Flow Margin: Johnson and Johnson had net cash outflow in III. Quarter . Observing third quarter 2023 results within Major Pharmaceutical Preparations industry Johnson and Johnson has achieved highest Net Cash Flow Margin. While overall Net Cash Flow Margin ranking remained unchanged compare to previous …

Johnson And Johnson shares improved by 5.27 % during the preceding 30 days , meanwhile, JNJ shares improved by 3.46% over the course of the last five trading days. Johnson And Johnson shares trade only 8% above its 52 week low.

Some of JNJ competitors such as Pfizer, Abbots, and Merck Co. whose resources are also significantly greater in the healthcare industry, put pressure on Johnson & Johnson through lower pricing, dropping cost, constantly design new products, or update existing products and services to meet customer's demand and bring new customers to the fold.Johnson And Johnson OHLC Stock Charts, Monthly, Stock Quotes - CSIMarketJohnson & Johnson Common Stock (JNJ) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.The Top Johnson & Johnson competitors are Pfizer, Novartis, Glaxo Smith Kline, Bayer, Merck, Abbott, Roche and others. Johnson & Johnson is American multinational pharmaceutical and medical equipment, and consumer goods manufacturing company. It was established in the year 1886 and headquartered in New Jersey.NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson …JNJ-73763989 is an N-acetylgalactosamine conjugated short interfering RNA combination product consisting of two triggers in clinical development for chronic hepatitis B virus (HBV) infection treatment that induces a selective degradation of all HBV mRNA transcripts. Our aim is to characterize the plasma and liver pharmacokinetics (PK) of JNJ …Tools Learn Johnson & Johnson (JNJ) Alerts Watch Help Go To: Other Sectors containing Johnson & Johnson (JNJ) screen flipcharts download Competitors Competitors The Competitors page allows you to view information for other symbols found in the same sector.

J&J is now forecasting full-year sales of $98.80 billion to $99.80 billion, about $1 billion higher than the guidance provided in April. The company raised its 2023 adjusted earnings outlook to ...

The Top 7 Johnson & Johnson Competitors: Pfizer, Merck, GlaxoSmithKline, Bayer, Abbott, Bristol Myers Squibb, Medtronic. Together, including the revenue of J&J, they contribute nearly $342 billion in annual revenues to the medical sector. Their total employee count is close to 730,000.

The Business Model Canvas of Johnson & Johnson encompasses key elements such as customer segments, value propositions, channels, customer relationships, revenue streams, key resources, key activities, key partnerships, and cost structure. Some of the competitors of Johnson & Johnson include Pfizer, Merck & Co., Novartis, and Gilead Sciences.Jan 31, 2022 · JNJ reported $82.58 billion in revenue for the 2020 fiscal year—$43.13 billion from the United States while the remaining $39.45 billion came from international sources. Johnson & Johnson ... For breaking news and key market indexes, see Wall Street Breakfast's Pre-Market Snapshot MACRO AND HOUSING D.R.Johnson & Johnson's main competitors include Unilever, Abbott, GSK, Medtronic, Novartis, Pfizer, Procter & Gamble, Roche and Bayer. Compare Johnson & Johnson to its competitors by revenue, employee growth and other metrics at Craft. The Top Johnson & Johnson competitors are Pfizer, Novartis, Glaxo Smith Kline, Bayer, Merck, Abbott, Roche and others. Johnson & Johnson is American multinational pharmaceutical and medical equipment, and consumer goods manufacturing company. It was established in the year 1886 and headquartered in New Jersey.Dec 1, 2023 · Johnson & Johnson (NYSE:JNJ) pays an annual dividend of $4.76 per share and currently has a dividend yield of 3.14%. The company has been increasing its dividend for 61 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 35.34%. Below we look at the top 10 competitors of Johnson & Johnson. 1. Reckitt Benckiser: Reckitt Benckiser (RB) group PLC is a multinational group of British origin. The Company was formed in 1999 by merger between Reckitt & Colman PLC in UK and Benckiser NV from Ireland. It believes in 'Purpose with Passion' and has been active in improving the ...Jnj contact info: Phone number: (732) 626-5160 Website: www.jnjwarehouse.com What does Jnj do? Since 2003 JNJ has been providing valuable and comprehensive warehousing and distribution services to domestic and international clients.

JNJ: New York Stock Exchange: 0.250% Notes Due January 2022: JNJ22: New York Stock Exchange: 0.650% Notes Due May 2024: JNJ24C: New York Stock Exchange: ... • Competition based on cost-effectiveness, product performance, technological advances and patents attained by competitors; andBelow we look at the top 10 competitors of Johnson & Johnson. 1. Reckitt Benckiser: Reckitt Benckiser (RB) group PLC is a multinational group of British origin. The Company was formed in 1999 by merger between Reckitt & Colman PLC in UK and Benckiser NV from Ireland. It believes in 'Purpose with Passion' and has been active in improving the ...Sep 27, 2023 · The Top Johnson & Johnson competitors are Pfizer, Novartis, Glaxo Smith Kline, Bayer, Merck, Abbott, Roche and others. Johnson & Johnson is American multinational pharmaceutical and medical equipment, and consumer goods manufacturing company. It was established in the year 1886 and headquartered in New Jersey. Johnson And Johnson' Executive Officers and mambers of the Board - CSIMarketInstagram:https://instagram. nyseamerican ptnbest forex trading strategycan you buy otc on webullmoomoo customer service number Dec 1, 2023 · Johnson & Johnson pays an annual dividend of $4.76 per share and has a dividend yield of 3.0%. Eli Lilly and Company pays an annual dividend of $4.52 per share and has a dividend yield of 0.8%. Johnson & Johnson pays out 35.3% of its earnings in the form of a dividend. twilio tockinsiders buying stocks Slide 1 Strategic Analysis Case Study 2009 Jarryd Phillips, Jermaine West, Spencer Jacoby, Othniel Hyliger, Steven Pelletier 1 Slide 2 Overview Company Overview History Current… bluelinx holdings Johnson & Johnson ( NYSE: JNJ) is a legendary healthcare company with a renewed focus on its pharmaceutical and medtech segments, making it an excellent defensive pick. The recent selloff in JNJ ...Johnson & Johnson (JNJ) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.Effective Tax Rate Comment: On the trailing twelve months basis Company's effective tax rate in III. Quarter decreased compare to previous quarter to 16.43 %, below company's average Effective Tax Rate. Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Effective Tax Rate. While total ranking remained …